Disc Medicine (IRON) Total Current Liabilities (2020 - 2026)
Disc Medicine (IRON) posted quarterly Total Current Liabilities of $30.4 million for Q2 2026, up 47.34% year-over-year from $20.6 million in Q2 2025, and down 2.51% quarter-over-quarter from $31.1 million in Q1 2026.
Analysis
Disc Medicine (IRON) Total Current Liabilities (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Total Current Liabilities for 7 consecutive years, with $30.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 47.34% year-over-year to $30.4 million; the TTM figure through Jun 2026 stood at $30.4 million (up 47.34% YoY), while the FY2025 annual figure was $36.6 million, up 57.15% from the prior year.
- Total Current Liabilities slipped to $30.4 million in Q2 2026 per IRON's latest filing, from $31.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $36.6 million in Q4 2025 and bottomed at $1.5 million in Q3 2022.
- Historically, Total Current Liabilities has averaged $19.3 million across 5 years, with a median of $20.5 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities tumbled 88.44% — and 2023, when it jumped 884.7%.
- Disc Medicine's Total Current Liabilities stood at $22.6 million in 2022, then retreated by 5.04% to $21.4 million in 2023, then grew by 8.76% to $23.3 million in 2024, then soared by 57.15% to $36.6 million in 2025, then dropped by 17.14% to $30.4 million in 2026.
- Business Quant data shows IRON's Total Current Liabilities at $30.4 million in Q2 2026, $31.1 million in Q1 2026, and $36.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Disc Medicine | 3.08 Bn | 3.08 Bn | - | 30.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.36 Mn |
| Mar 31, 2026 | 31.14 Mn |
| Dec 31, 2025 | 36.64 Mn |
| Sep 30, 2025 | 26.74 Mn |
| Jun 30, 2025 | 20.61 Mn |
| Mar 31, 2025 | 18.74 Mn |
| Dec 31, 2024 | 23.32 Mn |
| Sep 30, 2024 | 25.47 Mn |
| Jun 30, 2024 | 20.31 Mn |
| Mar 31, 2024 | 14.85 Mn |
| Dec 31, 2023 | 21.44 Mn |
| Sep 30, 2023 | 14.42 Mn |
| Jun 30, 2023 | 9.68 Mn |
| Mar 31, 2023 | 9.98 Mn |
| Dec 31, 2022 | 22.58 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 6.44 Mn |
| Mar 31, 2022 | 12.67 Mn |
| Dec 31, 2021 | 13.42 Mn |
| Sep 30, 2021 | 12.66 Mn |